Baird Financial Group
DVAX

Baird Financial Group’s Dynavax Technologies DVAX Stock Holding History

Baird Financial Group’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,129
Closed -$217K – 1856
2025
Q4 		$217K Sell
14,129
-1,869
-12% -$20.6K ﹤0.01% 1715
2025
Q3 		$159K Buy
15,998
+2,323
+17% +$24.2K ﹤0.01% 1752
2025
Q2 		$136K Buy
+13,675
New +$144K ﹤0.01% 1731

Other funds holding DVAX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Baird Financial Group's DVAX Position: Q1 2026 in Review

Baird Financial Group sold out of Dynavax Technologies (DVAX) in Q1 2026, closing a stake of 14,129 shares — an estimated $217K sold.

Baird Financial Group first reported a position in DVAX in Q2 2025 and held it in 3 quarters. The position peaked at $217K in Q4 2025. 1 fund tracked by Wall St. Rank holds DVAX as of Q1 2026.

  • Baird Financial Group reported no remaining Dynavax Technologies position as of Q1 2026 after selling out during the quarter.
  • Baird Financial Group sold 14,129 Dynavax Technologies shares in Q1 2026, an estimated $217K.
  • Baird Financial Group first reported a position in Dynavax Technologies in Q2 2025 and held it in 3 quarters.
  • Baird Financial Group's Dynavax Technologies position peaked at $217K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Dynavax Technologies as of Q1 2026.

Based on Baird Financial Group's 13F filing for Q1 2026, filed 14 May 2026.